Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Fingolimod in the Treatment of New Coronavirus Pneumonia (COVID-19)

NCT04280588 is registered in ClinicalTrials.gov with First Affiliated Hospital of Fujian Medical University as lead sponsor.

NCT NCT04280588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04280588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Fingolimod in the Treatment of New Coronavirus Pneumonia (COVID-19)
Lead sponsor
First Affiliated Hospital of Fujian Medical University
Phase
Phase 2
Overall status
Withdrawn
Start date
February 22, 2020
Completion date
July 1, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease (covid-19)